US Patent Number
Melampomagnolide B is disclosed as a new antileukemic sesquiterpene. A biotin-conjugated derivative of melampomagnolide B was prepared to elucidate its mechanism of action. Prodrugs of Melampomagnolide B are disclosed.
University of Rochester, Rochester, NY (US), University of Kentucky Research Foundation, Lexington, KY (US)
Crooks, Peter A.; Jordan, Craig T.; Pei, Shanshan; and Nasim, Shama, "Melampomagnolide B Derivatives as Antileukemic and Cytotoxic Agents" (2014). Pharmaceutical Sciences Faculty Patents. 25.